MC1213A1 - Derives imidazoliques utiles comme medicaments - Google Patents

Derives imidazoliques utiles comme medicaments

Info

Publication number
MC1213A1
MC1213A1 MC781323A MC1323A MC1213A1 MC 1213 A1 MC1213 A1 MC 1213A1 MC 781323 A MC781323 A MC 781323A MC 1323 A MC1323 A MC 1323A MC 1213 A1 MC1213 A1 MC 1213A1
Authority
MC
Monaco
Prior art keywords
radical
acid addition
pyridyl
addition salt
solution
Prior art date
Application number
MC781323A
Other languages
English (en)
French (fr)
Inventor
E Krebs
A Krasso
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1213A1 publication Critical patent/MC1213A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MC781323A 1977-09-19 1978-08-31 Derives imidazoliques utiles comme medicaments MC1213A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78140 1977-09-19
CH814978 1978-07-28

Publications (1)

Publication Number Publication Date
MC1213A1 true MC1213A1 (fr) 1979-05-18

Family

ID=25702876

Family Applications (1)

Application Number Title Priority Date Filing Date
MC781323A MC1213A1 (fr) 1977-09-19 1978-08-31 Derives imidazoliques utiles comme medicaments

Country Status (36)

Country Link
US (2) US4182766A (en0)
EP (1) EP0001279B1 (en0)
JP (1) JPS5459274A (en0)
AR (1) AR224350A1 (en0)
AT (1) AT368152B (en0)
AU (1) AU519711B2 (en0)
BG (1) BG28708A3 (en0)
BR (1) BR7806148A (en0)
CA (1) CA1106849A (en0)
DD (1) DD138210A5 (en0)
DE (2) DE2840591A1 (en0)
DK (1) DK406578A (en0)
EG (1) EG13530A (en0)
ES (1) ES473451A1 (en0)
FI (1) FI64365C (en0)
FR (1) FR2403340A1 (en0)
GB (1) GB2004281B (en0)
GR (1) GR73069B (en0)
HU (1) HU176111B (en0)
IE (1) IE47363B1 (en0)
IL (1) IL55557A (en0)
IN (1) IN148930B (en0)
IT (1) IT1098858B (en0)
MC (1) MC1213A1 (en0)
MT (1) MTP835B (en0)
NL (1) NL7809529A (en0)
NO (1) NO149962C (en0)
NZ (1) NZ188405A (en0)
OA (1) OA06054A (en0)
PH (1) PH16342A (en0)
PL (1) PL114494B1 (en0)
PT (1) PT68573A (en0)
RO (1) RO75258A (en0)
SE (1) SE7809792L (en0)
SU (1) SU793390A3 (en0)
YU (1) YU216778A (en0)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
ZA825106B (en) * 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
IL71665A (en) * 1983-05-03 1988-05-31 Byk Gulden Lomberg Chem Fab Fluoro-(2-pyridyl-methylthio)-dioxolo-(and dioxino-)benzimidazoles,processes for their preparation and pharmaceutical compositions containing the same
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
DE3585252D1 (de) * 1984-07-06 1992-03-05 Fisons Plc Benzimidazole, und verfahren zu deren herstellung, deren formulierung und verwendung als magensaeuresekretionshemmende verbindungen.
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
EP0204215B1 (en) 1985-05-24 1993-08-11 G.D. Searle & Co. 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3701277A1 (de) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
EP0649305A1 (en) * 1992-07-08 1995-04-26 Monsanto Company Benzimidazoles for alleviating stomach ulcers in swine
WO1995029897A1 (en) 1994-04-29 1995-11-09 G.D. Searle & Co. METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
PL186605B1 (pl) * 1995-09-21 2004-01-30 Pharma Pass Llc Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) * 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
KR100463031B1 (ko) * 1997-05-26 2005-04-06 동아제약주식회사 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
EP1469839A2 (en) * 2002-01-25 2004-10-27 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
EP1648416A4 (en) * 2003-07-18 2012-03-28 Santarus Inc PHARMACEUTICAL FORMULATIONS FOR INHIBITING THE ACIDIC ACIDIFICATION AND MANUFACTURING AND USE METHOD
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008067037A2 (en) 2006-10-05 2008-06-05 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
GB1234058A (en0) * 1968-10-21 1971-06-03
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen

Also Published As

Publication number Publication date
NO149962C (no) 1984-07-25
NO783155L (no) 1979-03-20
OA06054A (fr) 1981-06-30
JPS5459274A (en) 1979-05-12
US4248880A (en) 1981-02-03
ES473451A1 (es) 1979-05-01
CA1106849A (en) 1981-08-11
DE2861237D1 (en) 1981-12-10
AU3981778A (en) 1980-03-20
FR2403340A1 (fr) 1979-04-13
FI64365C (fi) 1983-11-10
IT1098858B (it) 1985-09-18
DD138210A5 (de) 1979-10-17
DK406578A (da) 1979-03-20
AT368152B (de) 1982-09-27
IT7827861A0 (it) 1978-09-19
BR7806148A (pt) 1979-04-17
MTP835B (en) 1979-11-14
DE2840591A1 (de) 1979-03-29
IL55557A (en) 1982-02-28
IE47363B1 (en) 1984-03-07
EP0001279B1 (de) 1981-09-30
YU216778A (en) 1983-01-21
PT68573A (fr) 1978-10-01
GB2004281B (en) 1982-03-10
NL7809529A (nl) 1979-03-21
EG13530A (en) 1981-12-31
AR224350A1 (es) 1981-11-30
AU519711B2 (en) 1981-12-17
FR2403340B1 (en0) 1981-02-13
HU176111B (en) 1980-12-28
FI64365B (fi) 1983-07-29
RO75258A (ro) 1980-11-30
NO149962B (no) 1984-04-16
EP0001279A1 (de) 1979-04-04
BG28708A3 (bg) 1980-06-16
FI782847A7 (fi) 1979-03-20
PL209693A1 (pl) 1979-06-04
GR73069B (en0) 1984-01-30
SE7809792L (sv) 1979-03-20
GB2004281A (en) 1979-03-28
PH16342A (en) 1983-09-05
US4182766A (en) 1980-01-08
IE781878L (en) 1979-03-19
NZ188405A (en) 1981-03-16
ATA673378A (de) 1982-01-15
IN148930B (en0) 1981-07-25
IL55557A0 (en) 1978-12-17
SU793390A3 (ru) 1980-12-30
PL114494B1 (en) 1981-01-31

Similar Documents

Publication Publication Date Title
MC1213A1 (fr) Derives imidazoliques utiles comme medicaments
EP0005129B1 (en) Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation
US4472409A (en) 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
EP0389370A1 (fr) Nouveaux stéroides 19-Nor 3-céto comportant une chaîne en 17 aminosubstituée, leur procédé de préparation et les intermédiaires de ce procédé,leur application comme médicaments et les compositions pharmaceutiques les contenant
LU85248A1 (fr) Derives de thiazolidine,procede pour leur preparation et compositions pharmaceutiques les contenant
FR2720396A1 (fr) Nouveaux N-pyridyl carboxamides et dérivés leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
GB2196962A (en) Substituted 2-benzyl-mercapto-imidazoles and analogs useful as anti-inflammatory agents
WO1996020936A1 (en) Novel thiazolidin-4-one derivatives
KR900003368B1 (ko) 신규한 인데노티아졸 유도체의 제조방법
US4528298A (en) Antiinflammatory imidazole derivatives
EP0066242B1 (en) Tocopheryl ester of 5-substituted picolinic acid, process for its production, and pharmaceutical composition containing it
US4818760A (en) Derivatives of pyridylsulfinyl(benz-or thieno-)imidazoles and their use as gastric secretion inhibiting substances
HU194244B (en) Process for production of derivatives of new tieno /2,3-d/ imidasole and medical compounds containing thereof
FR2539417A1 (fr) Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent
EP0077083B1 (fr) Nouveaux dérivés de la thioformamide, leur préparation et les médicaments qui les contiennent
US4157340A (en) N,N'-[Bis(N-cyanoguanyl)]cystamine derivatives
MC1650A1 (fr) Derives de l'imidazole
JPS62230788A (ja) 抗潰瘍剤としての2−〔(2−ピリジル)メチルスルフイニル〕チエノイミダゾ−ル類
MC1438A1 (fr) Derives d'oxadiazolopyrimidine
US5192774A (en) Substituted acetamide derivatives, process for their preparation and antiulcer drug containing same
MC1962A1 (fr) Derives du benzimidazole
FR2528433A1 (fr) Nouveaux derives d'oxazinobenzothiazine-6,6-dioxyde, leur preparation et leur application en tant que medicaments
DE60013607T2 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
FR2511369A1 (fr) Nouveaux derives du dithiole-1,2 ylidene-3 ammonium, leur preparation et les medicaments qui les contiennent
JP2524420B2 (ja) ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤

Legal Events

Date Code Title Description
YP Annual fee paid